- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/26 - Two oxygen atoms, e.g. isatoic anhydride
Patent holdings for IPC class C07D 265/26
Total number of patents in this class: 39
10-year publication summary
|
3
|
2
|
5
|
2
|
2
|
2
|
6
|
3
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FMC Corporation | 838 |
5 |
| National Defense Medical Center | 37 |
3 |
| FMC IP Technology GmbH | 160 |
3 |
| Convergene LLC | 11 |
2 |
| The University of North Carolina at Charlotte | 258 |
2 |
| FMC Agro Singapore Pte. Ltd. | 37 |
2 |
| Navinta III Inc | 14 |
2 |
| PI Industries Ltd | 167 |
2 |
| BASF SE | 21053 |
1 |
| The Trustees of Columbia University in the City of New York | 3599 |
1 |
| Duke University | 3095 |
1 |
| ADAMA Makhteshim Ltd. | 522 |
1 |
| bioMerieux | 929 |
1 |
| Dipharma Francis S.r.l. | 50 |
1 |
| Incyte Corporation | 1032 |
1 |
| Mitsubishi Gas Chemical Company, Inc. | 3485 |
1 |
| National University Corporation University of Toyama | 166 |
1 |
| Norgine BV | 42 |
1 |
| Ranbaxy Laboratories Limited | 283 |
1 |
| Shionogi & Co., Ltd. | 842 |
1 |
| Other owners | 6 |